Results 201 to 210 of about 30,096 (334)

Corrigendum to "Normal sperm head morphometric reference values in fertile Asian males". [PDF]

open access: yesAsian J Androl
Jia YL   +8 more
europepmc   +1 more source

3D‐printed model for resection of positive surgical margins in robot‐assisted prostatectomy

open access: yesBJU International, Volume 135, Issue 4, Page 657-667, April 2025.
Objectives To improve precision of secondary resection (SR) after positive surgical margin (PSM) detection by frozen section (FS) during nerve‐sparing (NS) robot‐assisted radical prostatectomy (RARP) by employing a personalised three‐dimensional (3D)‐printed prostate model derived from pelvic magnetic resonance imaging (MRI).
Christian Engesser   +12 more
wiley   +1 more source

Methods and early findings from a study comparing next-generation sequencing versus traditional cultures for penile implants concerning for low-grade infection. [PDF]

open access: yesTransl Androl Urol
Henry GD   +9 more
europepmc   +1 more source

Guideline of guidelines: management of small testicular masses

open access: yesBJU International, EarlyView.
Objective To compare and summarise the most up to date international guidelines and major recommendations for the management of small testicular masses (STMs). Methods A systematic search was conducted in PubMed, EMBASE, Scopus, Google Scholar, and the Cochrane Library up to 1 November 2024.
Marco Tozzi   +7 more
wiley   +1 more source

Global Andrology Forum Clinical Practice Guidelines: Because Male Reproductive Health Matters! Introducing a Novel Approach to Address Common Yet Controversial Aspects of Male Infertility. [PDF]

open access: yesWorld J Mens Health
Pescatori E   +14 more
europepmc   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1654-1665, 15 March 2026.
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke   +30 more
wiley   +1 more source

Home - About - Disclaimer - Privacy